Hai Jiang

648 total citations
15 papers, 488 citations indexed

About

Hai Jiang is a scholar working on Infectious Diseases, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Hai Jiang has authored 15 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Clinical Biochemistry and 3 papers in Molecular Biology. Recurrent topics in Hai Jiang's work include Antimicrobial Resistance in Staphylococcus (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Geological and Geochemical Analysis (2 papers). Hai Jiang is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Geological and Geochemical Analysis (2 papers). Hai Jiang collaborates with scholars based in China, United States and Netherlands. Hai Jiang's co-authors include Samantha Good, William O’Riordan, Greg Moeck, G. Ralph Corey, Heidi Kabler, Philip Giordano, Antonio L. Pérez, Matthew A. Wikler, J. Scott Overcash and Christopher Lucasti and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and Journal of Petrology.

In The Last Decade

Hai Jiang

15 papers receiving 467 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Hai Jiang 336 210 177 131 81 15 488
Samantha Good 334 1.0× 210 1.0× 174 1.0× 130 1.0× 81 1.0× 6 434
Heidi Kabler 217 0.6× 130 0.6× 102 0.6× 85 0.6× 73 0.9× 11 471
J. Scott Overcash 373 1.1× 193 0.9× 157 0.9× 174 1.3× 175 2.2× 25 722
Ashwin Porwal 177 0.5× 112 0.5× 90 0.5× 72 0.5× 41 0.5× 23 303
Karen Amsler 257 0.8× 140 0.7× 67 0.4× 233 1.8× 231 2.9× 15 593
Paul Bien 512 1.5× 138 0.7× 42 0.2× 152 1.2× 113 1.4× 18 634
Amy A. Watters 219 0.7× 109 0.5× 35 0.2× 58 0.4× 97 1.2× 12 336
Robert Skinner 214 0.6× 98 0.5× 45 0.3× 129 1.0× 64 0.8× 13 398
Jennifer I. Smart 185 0.6× 78 0.4× 34 0.2× 112 0.9× 76 0.9× 28 366
Jie Peng 171 0.5× 75 0.4× 38 0.2× 150 1.1× 71 0.9× 12 305

Countries citing papers authored by Hai Jiang

Since Specialization
Citations

This map shows the geographic impact of Hai Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai Jiang more than expected).

Fields of papers citing papers by Hai Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hai Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai Jiang. The network helps show where Hai Jiang may publish in the future.

Co-authorship network of co-authors of Hai Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Hai Jiang. A scholar is included among the top collaborators of Hai Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai Jiang. Hai Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
3.
Deng, Wensheng, Xiaohua Jiang, Yi Cao, et al.. (2023). Soluble epoxide hydrolase deficiency promotes liver regeneration and ameliorates liver injury in mice by regulating angiocrine factors and angiogenesis. Biochimica et Biophysica Acta (BBA) - General Subjects. 1867(9). 130394–130394. 4 indexed citations
4.
5.
Jiang, Hai, et al.. (2021). Two new polyacetylene glucosides and a new caffeoyl derivative with angiogenic activity from Bidens parviflora Willd.. Phytochemistry Letters. 42. 82–86. 6 indexed citations
6.
Jiang, Hai, et al.. (2021). The combined efficacy of adalimumab with GMA method on the treatment of ulcerative colitis and repair of intestinal mucosal lesion.. American Journal of Translational Research. 13(5). 5156–5164. 9 indexed citations
7.
Wu, Zhijun, Qiang Liu, Chunmin Wang, et al.. (2017). A Comparative Benchmark Dose Study for N, N-Dimethylformamide Induced Liver Injury in a Chinese Occupational Cohort. Toxicological Sciences. 158(1). 140–150. 20 indexed citations
8.
Corey, G. Ralph, Francis F. Arhin, Matthew A. Wikler, et al.. (2016). Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus. International Journal of Antimicrobial Agents. 48(5). 528–534. 28 indexed citations
9.
10.
Corey, G. Ralph, Heidi Kabler, Purvi Mehra, et al.. (2014). Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections. New England Journal of Medicine. 370(23). 2180–2190. 226 indexed citations
11.
Corey, G. Ralph, Samantha Good, Hai Jiang, et al.. (2014). Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study. Clinical Infectious Diseases. 60(2). 254–262. 169 indexed citations
12.
Corey, Ralph, et al.. (2014). 685Time to Onset and Duration of Adverse Events in Patients with Acute Bacterial Skin and Skin Structure Infections Treated with Oritavancin – The SOLO Studies. Open Forum Infectious Diseases. 1(suppl_1). S194–S194. 1 indexed citations
13.
Pollack, Charles V., et al.. (2014). 252 Efficacy Outcomes by Lesion Type in Studies of a Single Dose of Oritavancin Compared to 7 to 10 Days of Vancomycin. Annals of Emergency Medicine. 64(4). S90–S90. 1 indexed citations
14.
Corey, Ralph, Matthew A. Wikler, Greg Moeck, Hai Jiang, & Samantha Good. (2014). 1331The SOLO Studies: A Single-Dose of Oritavancin (ORI) Compared to 7-10 Days of Vancomycin (VAN) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI). Open Forum Infectious Diseases. 1(suppl_1). S55–S55. 2 indexed citations
15.
Liu, Ben, et al.. (2009). [Replacement of plaque by buccal mucosa in the treatment of Peyronieś disease: a report of 27 cases].. PubMed. 15(1). 45–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samantha Good Breakdown of academic impact, for papers by Heidi Kabler Breakdown of academic impact, for papers by J. Scott Overcash Breakdown of academic impact, for papers by Ashwin Porwal Breakdown of academic impact, for papers by Karen Amsler Breakdown of academic impact, for papers by Paul Bien Breakdown of academic impact, for papers by Amy A. Watters Breakdown of academic impact, for papers by Robert Skinner Breakdown of academic impact, for papers by Jennifer I. Smart Breakdown of academic impact, for papers by Jie Peng
Rankless by CCL
2026